|
Alpha Thalassemia (3)
Hemoglobin H disease is characterized by one functional gene that
codes for the production of alpha globins (--/-a).
Hgb H disease should be considered in the case of a neonate in whom all
of the red blood cells are very hypochromic. These neonates have a high
percentage of hemoglobin Bart's on the their newborn screening results.
In older children, this hemoglobinopathy is characterized by moderate
anemia with a hemoglobin in the 8 to 10 gm/dL range, hypochromia, microcytosis,
red cell fragmentation, and a fast migrating hemoglobin (Hgb H) on electrophoresis.
Hemoglobin H does not function as a normal hemoglobin and has a high oxygen
affinity
(holds onto oxygen longer making it unavaible for use by the body), so
the measured hemoglobin in these children is misleading. Individuals who
have Hgb H generally have a persistent stable state of anemia, which may
be accentuated by increased hemolysis during viral infections and by exposure
to oxidant medications, chemicals and foods such as sulfa drugs, benzene,
and fava beans (similar to individuals who have G6PD deficiency). As the
red cells mature they loose their ability to withstand oxidant stress
and Hgb H precipitates, leading to hemolysis. Therapy for individuals
who have Hgb H disease includes folate, avoidance of oxidant drugs and
foods, genetic counseling education and frequent medical care. Uncommon
occurrences in a child with Hgb H would be severe anemia, cholelithiasis,
skin ulceration, and splenomegaly
requiring splenectomy. Unlike individuals who have beta thalassemia, hemosiderosis
is rare in Hgb H disease.
Children with Hemoglobin H-Constant Spring (--/acsa)
have a more severe course than children who have Hgb H. They have a more
severe anemia, with a steady state hemoglobin ranging between 7 and 8
gm/dl. They more frequently have splenomegaly and severe anemia with febrile
illnesses and viral infections, often requiring transfusion. If anemia
is chronically severe and the child has splenomegaly, a splenectomy may
be performed. If splenectomy is
anticipated, the complication of severe post-splenectomy thrombocytosis
with hypercoagulability
can occur, leading to thrombosis
of the splenic vein or hepatic
veins. This complication has also been reported as recurrent pulmonary
emboli and clotting diathesis.
At CHO, children who are scheduled to have surgery are treated pre-surgically
with low molecular weight heparin, followed by low dose aspirin, continued
indefinitely. <next>
<page 1> <page
2> <page 3> <page 4>
|